Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03814304 · ClinicalTrials.gov registry record · NA

Personalized tDCS in Elderly Fallers Study

A NA study, sponsored by Hebrew SeniorLife.

Completed
Registry status
NA
Development phase
118
Enrollment target

NCT03814304: Completed NA study, sponsored by Hebrew SeniorLife.

NCT03814304 is a NA study that has completed, run by Hebrew SeniorLife. The registered enrollment target is 118 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03814304, a NA study, has completed, sponsored by Hebrew SeniorLife.

COMPLETED
Registry status
NA
Development phase
118 participants
Enrollment target

Study Summary

The objective of this study is to determine if a four-week, 20-session intervention of personalized transcranial direct current stimulation (tDCS), as compared to sham intervention, improves dual task standing and walking performance (Aim 1), as well as other physical (Aim 2) and cognitive (Aim 3) factors on the causal pathway to falls, in older adults who report two or more falls within the past year and fear of falling again in the future, yet who do not have any acute or over neurological or musculoskeletal condition. Primary endpoints will include the "dual task" costs to gait speed when walking and postural sway speed when standing, as induced by performing a serial subtraction cognitive task (i.e., \[(speeddual task - speedsingle task) / speedsingle task) X 100\] (Aim 1), the Short Physical Performance Battery (Aim 2), and the Trail Making Test (Part B minus Part A) (AIM 3). Secondary endpoints will include the dual task cost to serial subtraction performance, additional gait and balance outcomes derived from the dual task paradigm, the Timed Up-and-Go, fear of falling, habitual physical activity, and performance within a battery of neuropsychological tests focused on global cognitive function, attention, verbal fluency and memory.

Primary Outcome

This metric will assess the change from baseline in the degree to which performing a secondary cognitive task diminishes gait speed. The dual-task cost (DTC) to gait speed is calculated by (dual-task gait speed-single-task gait speed)/single-task gait speed \*100. Greater reduction in DTC to gait speed from baseline to post intervention indicates better performance.

Interventions

  • OTHER Active-Sham
  • OTHER Personalized tDCS

Trial Details

FieldValue
Enrollment Target 118 participants
Start Date 2019-07-08
Est. Completion 2025-07-31
Phase NA
Hebrew SeniorLife

32 total trials

What the finished NCT03814304 record still lists

NCT03814304 is an interventional study that assigns participants to a tested intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 2 interventions - of which Active-Sham is the first listed.

NCT03814304 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03814304 about?

NCT03814304 is a clinical study titled "Personalized tDCS in Elderly Fallers Study". The objective of this study is to determine if a four-week, 20-session intervention of personalized transcranial direct current stimulation (tDCS), as compared to sham intervention, improves dual task standing and walking performance (Aim 1), as well as other physical (Aim 2) and cognitive (Aim 3) f...

What is the current status of trial NCT03814304?

This trial is currently completed. It is a NA study. The enrollment target is 118 participants. The study started on 2019-07-08. Estimated completion is 2025-07-31.

What interventions are being tested in trial NCT03814304?

The interventions under investigation include: Active-Sham (OTHER), Personalized tDCS (OTHER).

Who is sponsoring clinical trial NCT03814304?

This trial is sponsored by Hebrew SeniorLife, which has 32 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03814304's enrollment target sits among peer trials

118 803rd of 2000 higher than 1,194 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03821623 · 118 participants · Phase 2

    Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults

  • NCT04040959 · 118 participants · Phase 2

    Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD

  • NCT04696029 · 118 participants · Phase 2

    DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

  • NCT05223192 · 118 participants · NA

    The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03814304, the US trial registry maintained by the National Library of Medicine. NCT03814304 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.